Sees FY23 revenue $3.55B-$3.62B, consensus $3.38B. Port, stated, "We are very humbled by what we were able to accomplish in 2022 while dealing with so many unusual challenges, but we also know we can still be so much better and are excited about the enormous potential within our portfolio as we continue to apply our proven locally-driven healthcare model. We are issuing our annual 2023 earnings guidance of $4.60 to $4.74 per diluted share and annual revenue guidance of $3.55 billion to $3.62 billion. The midpoint of this 2023 earnings guidance represents an increase of 12.8% over our 2022 results and is 28.3% higher than our 2021 results."
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on ENSG:
- The Ensign Group Reports Fourth Quarter and Fiscal Year 2022 Results; Issues 2023 Guidance
- Sabra provides update on disposition activity and North American transition
- The Ensign Group Closes on Expansion in California
- The Ensign Group Schedules Year-End 2022 Earnings Call for Friday, February 3, 2023
- The Ensign Group, Inc. Increases Quarterly Dividend to $0.0575 Per Share
